// App-Quantinova.ai

POS-080 : miR-155 Deficiency Protects Renal Tubular Epithelial Cells From Telomeres And Genomic DNA Damage In Cisplatin-Induced Acute Kidney Injury

Researchers

Presenter

  • Q. Yin

Principal Investigators

  • B. Wang

  • B.C. Liu

Medical Centers

  • Institute of Nephrology, Zhong Da Hospital- Southeast University School of Medicine, Nanjing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Acute renal failure

Biomarkers

  • Creatinine

  • microRNA-155

Drug/Treatment

  • Cisplatin

  • miR155

  • MD 1003

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final